Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ElectroCore Inc chart...

About the Company

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.

Exchange

NASDAQ

$6M

Total Revenue

73

Employees

$35M

Market Capitalization

-2.45

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ECOR News

electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript

12d ago, source: InvestingChannel on MSN

March 13, 2024 electroCore, Inc. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.55. ECOR ...

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

15d ago, source: Business Insider

About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS ...

electroCore to Participate in Upcoming Investor Conferences

16d ago, source:

ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...

Q4 2023 electroCore, Inc. Earnings Call

14d ago, source:

Hello, and welcome to the electroCore Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast. (Operator Instructions) At this time, I'd like to turn the call over to Dan Goldberger, ...

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

14d ago, source: Stockhouse

ROCKAWAY, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (the “Company”), a commercial-stage bioelectronic medicine and wellness company, today ...

electroCore to Participate in Upcoming Investor Conferences

16d ago, source: ADVFN

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy Officer, Joshua Lev, is scheduled to attend ...

electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript

14d ago, source: Seeking Alpha

Hello, and welcome to the electroCore Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.

electroCore, Inc.: electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

13d ago, source:

Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY, N.J.

Q4 2023 electroCore, Inc. Earnings Call

14d ago, source: Yahoo Finance

Q4 2023 electroCore, Inc. Earnings Call ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...